American authorities approved an experimental drug for emergency use on coronavirus patients, as more US states eased pandemic lockdowns despite another spike in deaths from the disease.

US approves Remdesivir as several states ease lockdown

A US drug trial has found that Remdesivir has a 'clear-cut' effect in stopping the Coronavirus. But, experts say doctors should not begin prescribing it to all patients.

Coronavirus Pandemic: Remdesivir showing signs of a potential COVID-19 drug

Coronavirus: Is this drug the ultimate cure? | Gravitas

Anti-viral drug remdesivir which was being hailed as the cure for the novel coronavirus, has failed its first clinical test. According to draft documents accidentally published by the World Health Organization, a Chinese trial showed that the drug did not improve patients' condition or reduce the pathogen's presence in the bloodstream.

Anti-viral drug being hailed as coronavirus cure, fails first clinical trial

COVID-19 patients, who are being administered an experimental drug called remdesivir, have been recovering quickly, with most going home in days or a few weeks. There is no approved therapy for COVID-19, which can cause severe pneumonia and acute respiratory distress syndrome in some patients.

COVID-19 patients recovering quickly after getting remdesivir, an experimental drug

Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed the survival rate of as much as 90per cent in a clinical trial in Congo.

Scientists hail promise of first effective Ebola treatments in Congo trial

remdesivir

Remdesivir, News on Remdesivir, stories on Remdesivir, articles on Remdesivir, Remdesivir stories at Wion, Remdesivir news, Remdesivir latest news